Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA

References

• Bennett EA, Keller H, Mills RE, Schmidt S, Moran JV, Weichenrieder O, Devine SE. (2008). Active Alu retrotransposons in the human genome. Genome Res 18:1875–1883.
   PubMed Web of Science ®Google Scholar
• Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, Medeiros R. (2008). Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol 27:415–421.
   PubMed Web of Science ®Google Scholar
• Cejas P, López-Gómez M, Aguayo C, Madero R, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Larrauri J, López R, Casado E, Gonzalez-Barón M, Feliu J. (2009). KRAS mutations in primary colorectal cancer tumors and related metastases: A potential role in prediction of lung metastasis. PLoS ONE 4:e8199.
   PubMed Web of Science ®Google Scholar
• Chang HW, Lee SM, Goodman SN, Singer G, Cho SK, Sokoll LJ, Montz FJ, Roden R, Zhang Z, Chan DW, Kurman RJ, Shih IeM. (2002). Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 94:1697–1703.
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA Jr. (2008). Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985–990.
   PubMed Web of Science ®Google Scholar
• Fiegl H, Millinger S, Mueller-Holzner E, Marth C, Ensinger C, Berger A, Klocker H, Goebel G, Widschwendter M. (2005). Circulating tumor-specific DNA: A marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res 65:1141–1145.
   PubMed Web of Science ®Google Scholar
• García-Olmo DC, Gutiérrez-González L, Samos J, Picazo MG, Atiénzar M, García-Olmo D. (2006). Surgery and hematogenous dissemination: Comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats. Ann Surg Oncol 13:1136–1144.
   PubMed Web of Science ®Google Scholar
• García-Olmo DC, Samos J, Picazo MG, Asensio AI, Toboso I, García-Olmo D. (2008). Release of cell-free DNA into the bloodstream leads to high levels of non-tumor plasma DNA during tumor progression in rats. Cancer Lett 272:133–140.
   PubMed Web of Science ®Google Scholar
• Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chassé E, Ratschiller D, Weder W, Joerger M, Betticher DC, Stahel RA, Ziegler A. (2004). Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22:4157–4164.
   PubMed Web of Science ®Google Scholar
• Iverson C, Larson G, Lai C, Yeh LT, Dadson C, Weingarten P, Appleby T, Vo T, Maderna A, Vernier JM, Hamatake R, Miner JN, Quart B. (2009). RDEA119/BAY 869766: A potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res 69:6839–6847.
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R. (2001). DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659–1665.
   PubMed Web of Science ®Google Scholar
• Jung K, Fleischhacker M, Rabien A. (2010). Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature. Clin Chim Acta 411:1611–1624.
   PubMed Web of Science ®Google Scholar
• Kamat AA, Bischoff FZ, Dang D, Baldwin MF, Han LY, Lin YG, Merritt WM, Landen CN Jr, Lu C, Gershenson DM, Simpson JL, Sood AK. (2006). Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther 5:1369–1374.
   PubMed Web of Science ®Google Scholar
• Koffler D, Agnello V, Winchester R, Kunkel HG. (1973). The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 52:198–204.
   PubMed Web of Science ®Google Scholar
• Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. (1977). Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646–650.
   PubMed Web of Science ®Google Scholar
• Leon SA, Ehrlich GE, Shapiro B, Labbate VA. (1977). Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol 4:139–143.
   PubMed Web of Science ®Google Scholar
• Li CN, Hsu HL, Wu TL, Tsao KC, Sun CF, Wu JT. (2003). Cell-free DNA is released from tumor cells upon cell death: A study of tissue cultures of tumor cell lines. J Clin Lab Anal 17:103–107.
   PubMed Web of Science ®Google Scholar
• Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. (1999). Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218–224.
   PubMed Web of Science ®Google Scholar
• Mendel P, Metais P. (1948). Les acides nucleiques du plasma sanguin chez l´homme. C R Acad Sci Paris 142:241–243.
   Google Scholar
• Mouliere F, Robert B, Arnau Peyrotte E, Del Rio M, Ychou M, Molina F, Gongora C, Thierry AR. (2011). High fragmentation characterizes tumour-derived circulating DNA. PLoS ONE 6:e23418.
   PubMed Web of Science ®Google Scholar
• Rago C, Huso DL, Diehl F, Karim B, Liu G, Papadopoulos N, Samuels Y, Velculescu VE, Vogelstein B, Kinzler KW, Diaz LA Jr. (2007). Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 67:9364–9370.
   PubMed Web of Science ®Google Scholar
• Samos J, García-Olmo DC, Picazo MG, Rubio-Vitaller A, García-Olmo D. (2006). Circulating nucleic acids in plasma/serum and tumor progression: Are apoptotic bodies involved? An experimental study in a rat cancer model. Ann N Y Acad Sci 1075:165–173.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Weickmann S, Witt C, Fleischhacker M. (2008). Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann N Y Acad Sci 1137:207–213.
   PubMedGoogle Scholar
• Schneider T, Osl F, Friess T, Stockinger H, Scheuer WV. (2002). Quantification of human Alu sequences by real-time PCR–an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin Exp Metastasis 19:571–582.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Stoehlmacher J, Pantel K, Goekkurt E. (2008). Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann N Y Acad Sci 1137:190–196.
   PubMed Web of Science ®Google Scholar
• Shapiro B, Chakrabarty M, Cohn EM, Leon SA. (1983). Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51:2116–2120.
   PubMed Web of Science ®Google Scholar
• Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P. (2000). The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906:161–168.
   PubMed Web of Science ®Google Scholar
• Su YH, Wang M, Brenner DE, Norton PA, Block TM. (2008). Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps. Ann N Y Acad Sci 1137:197–206.
   PubMed Web of Science ®Google Scholar
• Sunami E, Vu AT, Nguyen SL, Giuliano AE, Hoon DS. (2008). Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer. Ann N Y Acad Sci 1137:171–174.
   PubMed Web of Science ®Google Scholar
• Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M, Del Rio M, Molina F. (2010). Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 38:6159–6175.
   PubMed Web of Science ®Google Scholar
• van der Vaart M, Pretorius PJ. (2008). Circulating DNA. Its origin and fluctuation. Ann N Y Acad Sci 1137:18–26.
   PubMed Web of Science ®Google Scholar
• van der Drift MA, Hol BE, Klaassen CH, Prinsen CF, van Aarssen YA, Donders R, van der Stappen JW, Dekhuijzen PN, van der Heijden HF, Thunnissen FB. (2010). Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer. Lung Cancer 68:283–287.
   PubMed Web of Science ®Google Scholar
• Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA; Committee of the National Cancer Research Institute. (2010). Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555–1577.
   PubMed Web of Science ®Google Scholar
• Ziegler A, Zangemeister-Wittke U, Stahel RA. (2002). Circulating DNA: A new diagnostic gold mine? Cancer Treat Rev 28:255–271.
   PubMed Web of Science ®Google Scholar
• Zitt M, Müller HM, Rochel M, Schwendinger V, Zitt M, Goebel G, Devries A, Margreiter R, Oberwalder M, Zeillinger R, Ofner D. (2008). Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: A potential diagnostic tool for therapy monitoring. Dis Markers 25:159–165.
   PubMed Web of Science ®Google Scholar